KRISTIN PALMER — Lobbyist Profile | Poliscope

KRISTIN PALMER

Filings

Clients

Firms

Years active

2018–2019

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
American Society of Clinical Oncology, Inc.	8	2018–2019

Lobbying firms

Firm	Filings	Years
American Society of Clinical Oncology, Inc.	8	2018–2019

Bills explicitly cited in this lobbyist’s assigned issues (69)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1730

Cancer Drug Parity Act of 2019

Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Open original LDA filing ↗

Cited source text

Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279/S. 2546) Palliative Care Hospice Education and Training Act (H.R. 647/S. 2080) Access to Infertility Treatment and Care Act (H.R. 2803/ S. 1461) The Prescription Drug Pricing Reduction Act (S. 2543) Mitigating Emergency Drug Shortages Act (S. 2723)

H.R. 1730

Cancer Drug Parity Act of 2019

Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Open original LDA filing ↗

Cited source text

Original LDA source filings (8)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY

2019 · fourth_quarter · Q4

Firm income: —Client expense: $121,836Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

BUD

Budget/Appropriations

Funding for the National Institute of Health including the National Cancer Institute, and the Food, and Drug Administration including the Oncology Centers of Excellence and funds authorized by the Tobacco Control Act.

HCR

Health Issues

Cancer Drug Parity Act (H.R. 1730/S. 741) Safe Step Act (H.R. 2279/S. 2546) Palliative Care Hospice Education and Training Act (H.R. 647/S. 2080) Access to Infertility Treatment and Care Act (H.R. 2803/ S. 1461) The Prescription Drug Pricing Reduction Act (S. 2543) Mitigating Emergency Drug Shortages Act (S. 2723)

Source: Senate LDA

Show 4 more original filings

AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY

2018 · fourth_quarter · Q4

Firm income: —Client expense: $79,366Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative

TOB

Tobacco

H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY

2018 · third_quarter · Q3

Firm income: —Client expense: $223,857Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative

TOB

Tobacco

H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY

2018 · second_quarter · Q2

Firm income: —Client expense: $62,560Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TOB

Tobacco

H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act

BUD

Budget/Appropriations

FY 2018 and FY 2019 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

AMERICAN SOCIETY OF CLINICAL ONCOLOGY via AMERICAN SOCIETY OF CLINICAL ONCOLOGY

2018 · first_quarter · Q1

Firm income: —Client expense: $37,103Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

TOB

Tobacco

H.R.1136 FDA Deeming Authority Clarification Act of 2017 S.294/H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017 H.R. 4273/S.2100 Tobacco to 21 Act

BUD

Budget/Appropriations

FY 2017 and FY 2018 appropriations related to the National Institutes of Health (NIH), National Cancer Institute (NCI),Food and Drug Administration (FDA), and the Cancer Moonshot Initiative

Filing targets: HOUSE OF REPRESENTATIVES, SENATE